Harvard Bioscience Inc. (HBIO): Market Capitalization-to-Revenue Ratio

Symbol and logo of brand Harvard Bioscience (HBIO)

Steady demand for laboratory equipment provides Harvard Bioscience (HBIO) with a consistent cash flow. The company leverages the Life Sciences B2B segment through well-known brands, utilizing contract assembly and global service outsourcing. The price-to-sales valuation clearly demonstrates the asset's current position, where the metric value is 0.50, allowing investors to determine the extent of the business premium.

Price-to-Revenue Ratio: Harvard Bioscience, Inc. (HBIO) for 07/04/2022 - 11/13/2026

Metric breakdowns and analytics for Harvard Bioscience (HBIO)

- stock quotes and analyst forecast:
Price Harvard Bioscience Inc.|HBIO - Price Target Chart
- stock exchange capitalization data:
Market Value Harvard Bioscience|HBIO - Real Price to Acquire Entire Company
- book capitalization indicators:
Book Value per Share Harvard Bioscience|HBIO - Company Book Value|Market Cap to Net Assets Ratio harvardbioscience.com|HBIO - Company Total Assets
- business debt structure and liquidity details:
Debt to Capital Harvard Bioscience|HBIO - Long-Term Debt to Equity|Short-Term Debt to Capital Ratio harvardbioscience.com|HBIO - Company Total Debt|Debt to Book Capital Harvard Bioscience|HBIO - Company Long-Term Debt|Short-Term Debt Volume Harvard Bioscience|Intermediate Coverage Ratio harvardbioscience.com
- company profitability and valuation multiples indicators:
HBIO - Net Profit|Projected Future Earnings Harvard Bioscience|HBIO - Price to Earnings Ratio|Future Price to Earnings Multiple Harvard Bioscience Inc.|HBIO - Price/Earnings to Growth Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Harvard Bioscience|HBIO - Operating profit EBITDA|Net earnings per share (EPS TTM) Harvard Bioscience|HBIO - Earnings per share for the last twelve months|Year-over-year earnings per one share growth for the last 12 months harvardbioscience.com|HBIO - Earnings growth in current year|Projected earnings per share growth rate for next year Harvard Bioscience
- total revenue and sales volume data:
HBIO - Company Sales|Company Future Revenue harvardbioscience.com|HBIO - P/S Multiple|Price-to-Projected Revenue Ratio Harvard Bioscience
Summary company analytics:Harvard Bioscience Inc.
Mass-produced product of Harvard Bioscience Inc.

To minimize risks amid volatility, it is critical for investors to distinguish the intrinsic value of a business from market speculation. The P/S ratio relates market capitalization to annual sales volume, revealing whether an asset is overvalued or undervalued. By analyzing the average P/S of a company, one can determine how much the market is willing to pay for each unit of revenue. For Harvard Bioscience (HBIO), this metric reflects the investment attractiveness of their engineering developments in microfluidic chips and organ-on-a-chip systems.

Competitors of Harvard Bioscience

Market Cap to Sales Volume ISRG|Price-to-Revenue Ratio Danaher DHR|Market Capitalization-to-Revenue Ratio BDX|STE: Market Cap to Revenue|WST - P/S Multiple|Baxter International (BAX) - Price-to-Revenue Ratio|Market Cap to Revenue masimo.com|STVN (Stevanato Group) - P/S Multiple|Price to Sales Teleflex Inc. TFX|Price-to-Revenue Ratio Merit Medical Systems Inc (MMSI)|Nobel Biocare - Market Cap to Revenue Ratio|ICU Medical, Inc. - Market Cap to Revenue|Market Cap to Sales Volume XRAY (dentsplysirona.com)|LMAT - Price-to-Revenue Ratio|Price-to-Revenue Coefficient AtriCure Inc ATRC|STAA: P/S Multiple|Niagen - Market Capitalization-to-Revenue Ratio|ZIMV (ZimVie Inc.) - P/S Multiple|P/S Multiple angiodynamics.com|Price-to-Revenue Ratio Cerus (CERS)|TKNO (Alpha Teknova) - Market Capitalization-to-Revenue Ratio|Monogram Technologies Inc - Market Cap to Revenue|Sharps Technology Inc - Price-to-Revenue Ratio|InfuSystem Inc - P/S Multiple|UTMD - P/S Multiple|korumedical.com (KRMD) - Price-to-Revenue Ratio|Nyxoah SA - Market Capitalization-to-Revenue Ratio|MBOT (Microbot Medical Inc) - P/S Multiple|Market Cap to Revenue Ratio PDEX (Pro-Dex Inc.)|Market Cap to Revenue ZTEK (Zentek Ltd.)|ELUT (elutia.com) - Market Capitalization-to-Revenue Ratio|P/S Multiple MLSS (Milestone Scientific Inc.)|NEXGEL Inc. - Price-to-Revenue Ratio|Retractable Tech - P/S Multiple|Price-to-Revenue Coefficient Femasys Corporation FEMY|meihuamed.com (MHUA) - Price-to-Revenue Ratio|Price to Sales Predictive Oncology Inc. (POAI)|Price-to-Revenue Ratio Callan JMB Inc.|Atrion Corp. (ATRI) - Price-to-Revenue Coefficient|P/S Multiple NURO